BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36321614)

  • 1. The association of new-onset diabetes with subsequent diagnosis of pancreatic cancer-novel use of a large administrative database.
    White MJ; Sheka AC; LaRocca CJ; Irey RL; Ma S; Wirth KM; Benner A; Denbo JW; Jensen EH; Ankeny JS; Ikramuddin S; Tuttle TM; Hui JYC; Marmor S
    J Public Health (Oxf); 2023 Jun; 45(2):e266-e274. PubMed ID: 36321614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Prospective Study to Establish a New-Onset Diabetes Cohort: From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer.
    Maitra A; Sharma A; Brand RE; Van Den Eeden SK; Fisher WE; Hart PA; Hughes SJ; Mather KJ; Pandol SJ; Park WG; Feng Z; Serrano J; Rinaudo JAS; Srivastava S; Chari ST;
    Pancreas; 2018; 47(10):1244-1248. PubMed ID: 30325864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of pancreatic cancer in people with new-onset diabetes: A Danish nationwide population-based cohort study.
    Jensen MH; Cichosz SL; Hejlesen O; Henriksen SD; Drewes AM; Olesen SS
    Pancreatology; 2023 Sep; 23(6):642-649. PubMed ID: 37422338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes associated with pancreatic ductal adenocarcinoma is just diabetes: Results of a prospective observational study in surgical patients.
    Dugnani E; Gandolfi A; Balzano G; Scavini M; Pasquale V; Aleotti F; Liberati D; Di Terlizzi G; Petrella G; Reni M; Doglioni C; Bosi E; Falconi M; Piemonti L
    Pancreatology; 2016; 16(5):844-52. PubMed ID: 27546476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the Enriching New-Onset Diabetes for Pancreatic Cancer Model: A Retrospective Cohort Study Using Real-World Data.
    Boursi B; Patalon T; Webb M; Margalit O; Beller T; Yang YX; Chodick G
    Pancreas; 2022 Feb; 51(2):196-199. PubMed ID: 35404897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower plasma levels of glucose-dependent insulinotropic peptide (GIP) and pancreatic polypeptide (PP) in patients with ductal adenocarcinoma of the pancreas and their relation to the presence of impaired glucoregulation and weight loss.
    Škrha J; Bušek P; Uhrová J; Hrabal P; Kmochová K; Laclav M; Bunganič B; Frič P
    Pancreatology; 2017; 17(1):89-94. PubMed ID: 28027898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is diabetes onset at advanced age a sign of pancreatic cancer?
    Ozsay O; Karabacak U; Cetin S; Majidova N
    Ann Ital Chir; 2022; 93():476-480. PubMed ID: 36156490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus.
    Pretta A; Ziranu P; Puzzoni M; Lai E; Orsi G; Liscia N; Molinaro E; Mariani S; Riggi L; Rovesti G; Dubois M; Migliari M; Persano M; Saba G; Impera V; Musio F; Batzella E; Demurtas L; Pusceddu V; Astara G; Faloppi L; Casadei Gardini A; Andrikou K; Cascinu S; Scartozzi M
    Tumori; 2021 Dec; 107(6):550-555. PubMed ID: 33243068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood-based Migration Signature Biomarker Panel Discriminates Early Stage New Onset Diabetes related Pancreatic Ductal Adenocarcinoma from Type 2 Diabetes.
    Balasenthil S; Liu S; Dai J; Bamlet WR; Petersen G; Chari ST; Maitra A; Chen N; Sen S; McNeill Killary A
    Clin Chim Acta; 2023 Nov; 551():117567. PubMed ID: 37774897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and Risk of Pancreatic Cancer in Patients with a New Diagnosis of Chronic Pancreatitis.
    Munigala S; Subramaniam DS; Subramaniam DP; Burroughs TE; Conwell DL; Sheth SG
    Dig Dis Sci; 2022 Feb; 67(2):708-715. PubMed ID: 33630214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced mean platelet volume levels predict shorter survival in patients with resectable pancreatic ductal adenocarcinoma and type 2 diabetes.
    Yin JB; Li N; Cui MM; Wang X; Wang RT
    BMC Gastroenterol; 2020 May; 20(1):143. PubMed ID: 32393273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Evaluation of Gallstone Disease in the Year Before Pancreatic Cancer Diagnosis.
    Papageorge MV; de Geus SWL; Woods AP; Ng SC; McAneny D; Tseng JF; Kenzik KM; Sachs TE
    J Surg Res; 2023 Nov; 291():282-288. PubMed ID: 37481963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic Adenocarcinoma Causing Necrotizing Pancreatitis: Not as Rare as You Think?
    Lewellen KA; Maatman TK; Heimberger MA; Ceppa EP; House MG; Nakeeb A; Schmidt CM; Zyromski NJ
    J Surg Res; 2020 Jun; 250():53-58. PubMed ID: 32018143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of pancreatic cancer risk in patients with new-onset diabetes using a machine learning approach based on routine biochemical parameters.
    Cichosz SL; Jensen MH; Hejlesen O; Henriksen SD; Drewes AM; Olesen SS
    Comput Methods Programs Biomed; 2024 Feb; 244():107965. PubMed ID: 38070389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening.
    Cremin C; Lee MK; Hong Q; Hoeschen C; Mackenzie A; Dixon K; McCullum M; Nuk J; Kalloger S; Karasinska J; Scudamore C; Kim PTW; Donnellan F; Lam ECS; Lim HJ; Neben CL; Stedden W; Zhou AY; Schaeffer DF; Sun S; Renouf DJ; Schrader KA
    Cancer Med; 2020 Jun; 9(11):4004-4013. PubMed ID: 32255556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phases of Metabolic and Soft Tissue Changes in Months Preceding a Diagnosis of Pancreatic Ductal Adenocarcinoma.
    Sah RP; Sharma A; Nagpal S; Patlolla SH; Sharma A; Kandlakunta H; Anani V; Angom RS; Kamboj AK; Ahmed N; Mohapatra S; Vivekanandhan S; Philbrick KA; Weston A; Takahashi N; Kirkland J; Javeed N; Matveyenko A; Levy MJ; Mukhopadhyay D; Chari ST
    Gastroenterology; 2019 May; 156(6):1742-1752. PubMed ID: 30677401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter study of early pancreatic cancer in Japan.
    Kanno A; Masamune A; Hanada K; Maguchi H; Shimizu Y; Ueki T; Hasebe O; Ohtsuka T; Nakamura M; Takenaka M; Kitano M; Kikuyama M; Gabata T; Yoshida K; Sasaki T; Serikawa M; Furukawa T; Yanagisawa A; Shimosegawa T;
    Pancreatology; 2018 Jan; 18(1):61-67. PubMed ID: 29170051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New-Onset or Exacerbation of Diabetes Mellitus Is a Clue to the Early Diagnosis of Pancreatic Cancer.
    Takikawa T; Kikuta K; Kume K; Hamada S; Miura S; Yoshida N; Hongo S; Tanaka Y; Matsumoto R; Sano T; Ikeda M; Iseki M; Unno M; Masamune A
    Tohoku J Exp Med; 2020 Dec; 252(4):353-364. PubMed ID: 33342915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between use of statin or aspirin and pancreatic ductal adenocarcinoma: A nested case-control study in a Korean nationwide cohort.
    Choi JH; Lee SH; Huh G; Chun JW; You MS; Paik WH; Ryu JK; Kim YT
    Cancer Med; 2019 Dec; 8(17):7419-7430. PubMed ID: 31637875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive Models Screen New-Onset Diabetics at Low Risk of Early-Onset Pancreatic Cancer.
    Khan S; Al Heraki S; Kupec JT
    Pancreas; 2021 Oct; 50(9):1326-1330. PubMed ID: 34860819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.